AMY GARRISON: Open Payments
NPI 1902155880 · LAKE PLACID, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$684 in 33 payments from 9 companies in 2025. Trend: 2023 $153 · 2024 $709 · 2025 $684
Food & beverage: $684
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $190 |
| AstraZeneca Pharmaceuticals LP | 7 | $140 |
| ABBVIE INC. | 5 | $116 |
| Lilly USA, LLC | 3 | $62 |
| GlaxoSmithKline, LLC. | 3 | $53 |
| Neurocrine BioSciences, Inc. | 2 | $45 |
| Amgen Inc. | 2 | $38 |
| Astellas Pharma US Inc | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
Products named: Wegovy, MOUNJARO, FARXIGA, Ozempic, TRELEGY ELLIPTA, QULIPTA, AIRSUPRA, INGREZZA.
Industry payments across NY — which companies pay providers there.
